.

. &
-

.

.
1]
,

. 80%

( , ,
, , ...).
(Framingham Study, Strong Heart
Study),
.

, .
(Framingham Heart Study)
50
57
67% ( )
8 10 .


15 .
. 25%
.


( 1% HbA1c,
53%
8% ).

2 ,

(
UKPDS).
2]

 , per se,

.
(
, ,
C,
, stress),
, ,

.
2,
stress


.


.


(FFA). FFA
,
(GLUT)
. FFA
ROS, .
, .

,

.

LDL

stress

AgII

Stress

( 1)
3] ?
12

,

. NCEP
EAST WEST


,
7 .

( ).
(2009) 13 (38600
=13 )
43% . .
.

.
Strong Heart 5

..
.

. 41
48 .

(British Regional Heart Study)
(10 15 )
.



..

ADA 2009
10
score (Framingham risk score,
HeartScore, UKPDS engine, ).

.
4] . .


.
,
( LDL < 100m%)
( < 130/80mmHg),

 (
50 ,
60 )
. (. 2).

. .. Steno 2
50%
(NNT =8).

, .
(. 3
. .
.).



( UKPDS

/ 20 ).

/
.


.
: ,

.

.
CVD

2013
Statement ADA 2012

<130/ 80 mmHg

LDL

<100 mg/dl
.LDL
>40+ .. ()

LDL>100 . ()

-<150 mg/dl

DL

DL>40 mg/dl () >50 mg/dl ()

:75 -162 mg/ . >50

() >60 () 1
) (C)

- 1C <7%
1C (<6%)

(25)

5-7%

150 min/ .
90 min/ .

( 2)

 ,
. HbA1C

Diabetologia 2010;53:2079-2085

( 3)

1. T. Mazzone, A. Chati, J. Plutzky: Cardiovascular disease in type two

diabetes mellitus: insights from mechanistic studies. Lancet 2008; 371:18001809.
2.
Earl S. Ford, Z. Guixiang et al: Pre-Diabetes and the Risk for
Cardiovascular Disease: A Systematic Review of the Evidence. JACC 2010;
55:13101-1317
3. S. G. Wannamethee, A. G. Shaper, P. H. Whincup et al: Impact of
Diabetes on Cardiovascular Disease Risk and All-Cause Mortality in Older
Men: Influence of Age at Onset, Diabetes Duration, and Established and
Novel Risk Factors. Arch. Int. Med. 2011; 171: 404-410
4.
Standards of Medical Care in diabetes 2013. Diab. Care
2013;36:s11s66
5. . :
. 2010:

. . ,
2010 . 249-285
6. . :
. .
2007 . 535-557

7. M. Brownlee: The pathobiology of diabetic complications. Diabetes

2005;54: 1615-1624
8. B. Stratmann, D. Tschoepe. Atherogenesis and atherothrombosis Focus
on diabetes mellitus. Resp. Clin. Endocr. Metab. 2009;23: 291-303
9. G. Hostamisligil: Inflammation and metabolic disorders. Nature 2006;444:
860-867
10. American Diabetes Association. Medical Management of type 2
diabetes. Alexandria, VA, American Diabetes Associatiion, 2008
11. American Diabetes Association. Intensive Diabetes Management.
Alexandria. VA, American Diabetes Association, 2009
12. JS. Skyler, R. Bergenstal, RO. Bonow et al: Intensive glycemic control and
the prevention of cardiovascular events: implications of the ACCORD,
ADVANCE and VA diabetes trials: a position statement of the American
Diabetes Association and a scientific statement of the American College of
Cardiology Foundation and the American Heart Association. Diabetes Care
2009; 32:187 192
13. FM. Turnbull, C. Abraina, RJ. Anderson et al: Intensive glucose control
and macrovascular outcomes in type 2 diabetes. Diabetologia 2009;52: 22882298
14. JB. Buse, HN. Ginsberg, GL. Bakris et al.: Primary Prevention of
cardiovascular diseases in people with diabetes mellitus: a scientific
statement from the American Heart Association and the American Diabetes
Association. Diabetes Care 2007;30: 162-172
15. P. Gaede, H. Lund-Andersen, HH. Parving et al: Effect of a multifactorial
intervention on mortality in type two diabetes. NEJM 2008; 358: 580-591.
16. ES. Ford: Trends in the risk for coronary heart disease among adults with
diagnosed diabetes in the U.S.: findings from the National Health and
Nutrition Examination Survey, 1999-2008. Diabetes Care 2011;34: 13371343.